About this Journal Submit a Manuscript Table of Contents
Scientifica
Volume 2012 (2012), Article ID 205027, 19 pages
http://dx.doi.org/10.6064/2012/205027
Review Article

Stress in Obesity and Associated Metabolic and Cardiovascular Disorders

Atherosclerosis and Metabolism Unit, Department of Cardiovascular Sciences, KU Leuven, Herestraat 49, P.O. Box 705, 3000 Leuven, Belgium

Received 21 October 2012; Accepted 11 November 2012

Academic Editors: G. Lopaschuk and S. Parthasarathy

Copyright © 2012 Paul Holvoet. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. H. Goodpaster, S. Krishnaswami, H. Resnick et al., “Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women,” Diabetes Care, vol. 26, no. 2, pp. 372–379, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. J. I. Cleeman, “Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III),” The Journal of the American Medical Association, vol. 285, no. 19, pp. 2486–2497, 2001. View at Scopus
  3. E. S. Ford, “The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study,” Atherosclerosis, vol. 173, no. 2, pp. 309–314, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. S. M. Grundy, H. B. Brewer Jr., J. I. Cleeman, S. C. Smith Jr., and C. Lenfant, “Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition,” Circulation, vol. 109, no. 3, pp. 433–438, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Kahn, J. Buse, E. Ferrannini, and M. Stern, “The metabolic syndrome: time for a critical appraisal—Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes,” Diabetes Care, vol. 28, no. 9, pp. 2289–2304, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. C. J. Girman, T. Rhodes, M. Mercuri et al., “The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS),” American Journal of Cardiology, vol. 93, no. 2, pp. 136–141, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. K. J. Hunt, R. G. Resendez, K. Williams, S. M. Haffner, and M. P. Stern, “National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio heart study,” Circulation, vol. 110, no. 10, pp. 1251–1257, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Isomaa, M. Henricsson, P. Almgren, T. Tuomi, M. R. Taskinen, and L. Groop, “The metabolic syndrome influences the risk of chronic complications in patients with type II diabetes,” Diabetologia, vol. 44, no. 9, pp. 1148–1154, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. H. M. Lakka, D. E. Laaksonen, T. A. Lakka et al., “The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men,” The Journal of the American Medical Association, vol. 288, no. 21, pp. 2709–2716, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Lempiäinen, L. Mykkänen, K. Pyörälä, M. Laakso, and J. Kuusisto, “Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men,” Circulation, vol. 100, no. 2, pp. 123–128, 1999. View at Scopus
  11. S. Malik, N. D. Wong, S. S. Franklin et al., “Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults,” Circulation, vol. 110, no. 10, pp. 1245–1250, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Onat, K. Ceyhan, Ö. Başar, B. Erer, S. Toprak, and V. Sansoy, “Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels—a prospective and cross-sectional evaluation,” Atherosclerosis, vol. 165, no. 2, pp. 285–292, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. M. P. Stern, K. Williams, and K. J. Hunt, “Impact of diabetes/metabolic syndrome in patients with established cardiovascular disease,” Atherosclerosis Supplements, vol. 6, no. 2, pp. 3–6, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Zhang, Y. Wang, J. Zhang, B. J. Potter, J. R. Sowers, and C. Zhang, “Bariatric surgery reduces visceral adipose inflammation and improves endothelial function in type 2 diabetic mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 9, pp. 2063–2069, 2011.
  15. P. C. Calder, N. Ahluwalia, F. Brouns, et al., “Dietary factors and low-grade inflammation in relation to overweight and obesity,” British Journal of Nutrition, vol. 103, supplement 3, pp. S5–S78, 2011.
  16. R. Stienstra, C. J. Tack, T. D. Kanneganti, L. A. Joosten, and M. G. Netea, “The inflammasome puts obesity in the danger zone,” Cell Metabolism, vol. 15, no. 1, pp. 10–18, 2012.
  17. F. C. McGillicuddy, K. A. Harford, C. M. Reynolds et al., “Lack of interleukin-1 receptor I (IL-1RI) protects mice from high-fat diet-induced adipose tissue inflammation coincident with improved glucose homeostasis,” Diabetes, vol. 60, no. 6, pp. 1688–1698, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Vandanmagsar, Y. H. Youm, A. Ravussin et al., “The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance,” Nature Medicine, vol. 17, no. 2, pp. 179–188, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Tabata, T. Kadomatsu, S. Fukuhara et al., “Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance,” Cell Metabolism, vol. 10, no. 3, pp. 178–188, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Qatanani, N. R. Szwergold, D. R. Greaves, R. S. Ahima, and M. A. Lazar, “Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice,” The Journal of Clinical Investigation, vol. 119, no. 3, pp. 531–539, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Ohashi, J. L. Parker, N. Ouchi et al., “Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype,” The Journal of Biological Chemistry, vol. 285, no. 9, pp. 6153–6160, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. H. K. Dong, A. P. Burgess, M. Li et al., “Heme oxygenase-mediated increases in adiponectin decrease fat content and inflammatory cytokines tumor necrosis factor-α and interleukin-6 in Zucker rats and reduce adipogenesis in human mesenchymal stem cells,” Journal of Pharmacology and Experimental Therapeutics, vol. 325, no. 3, pp. 833–840, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. Z. B. Deng, A. Poliakov, R. W. Hardy et al., “Adipose tissue exosome-like vesicles mediate activation of macrophage-induced insulin resistance,” Diabetes, vol. 58, no. 11, pp. 2498–2505, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. S. P. Weisberg, D. Hunter, R. Huber et al., “CCR2 modulates inflammatory and metabolic effects of high-fat feeding,” The Journal of Clinical Investigation, vol. 116, no. 1, pp. 115–124, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Chavey, G. Lazennec, S. Lagarrigue et al., “CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistance,” Cell Metabolism, vol. 9, no. 4, pp. 339–349, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. X. Prieur, C. Y. L. Mok, V. R. Velagapudi et al., “Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice,” Diabetes, vol. 60, no. 3, pp. 797–809, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. J. M. Wentworth, G. Naselli, W. A. Brown et al., “Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity,” Diabetes, vol. 59, no. 7, pp. 1648–1656, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. C. N. Lumeng, J. Liu, L. Geletka, et al., “Aging is associated with an increase in T cells and inflammatory macrophages in visceral adipose tissue,” The Journal of Immunology, vol. 187, no. 12, pp. 6208–6216, 2011.
  29. M. Spite, J. Hellmann, Y. Tang, et al., “Deficiency of the leukotriene B4 receptor, BLT-1, protects against systemic insulin resistance in diet-induced obesity,” The Journal of Immunology, vol. 187, no. 4, pp. 1942–1949, 2011.
  30. S. Fujisaka, I. Usui, Y. Kanatani et al., “Telmisartan improves insulin resistance and modulates adipose tissue macrophage polarization in high-fat-fed mice,” Endocrinology, vol. 152, no. 5, pp. 1789–1799, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Fujisaka, I. Usui, A. Bukhari et al., “Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice,” Diabetes, vol. 58, no. 11, pp. 2574–2582, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. K. J. Strissel, Z. Stancheva, H. Miyoshi et al., “Adipocyte death, adipose tissue remodeling, and obesity complications,” Diabetes, vol. 56, no. 12, pp. 2910–2918, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. M. G. Farb, S. Bigornia, M. Mott et al., “Reduced adipose tissue inflammation represents an intermediate cardiometabolic phenotype in obesity,” Journal of the American College of Cardiology, vol. 58, no. 3, pp. 232–237, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Gao and C. Bing, “Macrophage-induced expression and release of matrix metalloproteinase 1 and 3 by human preadipocytes is mediated by IL-1beta via activation of MAPK signaling,” Journal of Cellular Physiology, vol. 226, no. 11, pp. 2869–2880, 2011.
  35. J. Kurokaw, H. Nagano, O. Ohara et al., “Apoptosis inhibitor of macrophage (AIM) is required for obesity-associated recruitment of inflammatory macrophages into adipose tissue,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 29, pp. 12072–12077, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Fischer-Posovszky, Q. A. Wang, I. W. Asterholm, J. M. Rutkowski, and P. E. Scherer, “Targeted deletion of adipocytes by apoptosis leads to adipose tissue recruitment of alternatively activated M2 macrophages,” Endocrinology, vol. 152, no. 8, pp. 3074–3081, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Hulsmans and P. Holvoet, “The vicious circle between oxidative stress and inflammation in atherosclerosis,” Journal of Cellular and Molecular Medicine, vol. 14, no. 1-2, pp. 70–78, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Hulsmans, D. De Keyzer, and P. Holvoet, “MicroRNAs regulating oxidative stress and inflammation in relation to obesity and atherosclerosis,” The FASEB Journal, vol. 25, no. 8, pp. 2515–2527, 2011.
  39. M. Hulsmans, E. Van Dooren, and P. Holvoet, “Mitochondrial reactive oxygen species and risk of atherosclerosis,” Current Atherosclerosis Reports, vol. 14, no. 3, pp. 264–276, 2012.
  40. K. S. Rogacev, C. Ulrich, L. Blömer et al., “Monocyte heterogeneity in obesity and subclinical atherosclerosis,” European Heart Journal, vol. 31, no. 3, pp. 369–376, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. K. G. M. M. Alberti, R. H. Eckel, S. M. Grundy et al., “Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International atherosclerosis society; and international association for the study of obesity,” Circulation, vol. 120, no. 16, pp. 1640–1645, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. R. Misra, T. Patel, P. Kotha et al., “Prevalence of diabetes, metabolic syndrome, and cardiovascular risk factors in US Asian Indians: results from a national study,” Journal of Diabetes and Its Complications, vol. 24, no. 3, pp. 145–153, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. C. van den Hooven, J. Ploemacher, and M. Godwin, “Metabolic syndrome in a family practice population: prevalence and clinical characteristics,” Canadian Family Physician, vol. 52, no. 8, pp. 982–983, 2006. View at Scopus
  44. S. P. Efstathiou, I. I. Skeva, E. Zorbala, E. Georgiou, and T. D. Mountokalakis, “Metabolic syndrome in adolescence: can it be predicted from natal and parental profile? The Prediction of Metabolic Syndrome in Adolescence (PREMA) study,” Circulation, vol. 125, no. 7, pp. 902–910, 2012.
  45. K. Khunti, N. Taub, J. Tringham et al., “Screening for the metabolic syndrome using simple anthropometric measurements in south Asian and white Europeans: a population-based screening study. The Leicester Ethnic Atherosclerosis and Diabetes Risk (LEADER) Study,” Primary Care Diabetes, vol. 4, no. 1, pp. 25–32, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. X. Q. Lao, Y. H. Zhang, M. C. Wong, et al., “The prevalence of metabolic syndrome and cardiovascular risk factors in adults in southern China,” BMC Public Health, vol. 12, article 64, 2012.
  47. G. D. Friedman, G. R. Cutter, R. P. Donahue et al., “CARDIA: study design, recruitment, and some characteristics of the examined subjects,” Journal of Clinical Epidemiology, vol. 41, no. 11, pp. 1105–1116, 1988. View at Scopus
  48. G. R. Cutter, G. L. Burke, A. R. Dyer et al., “Cardiovascular risk factors in young adults. The CARDIA baseline monograph,” Controlled Clinical Trials, vol. 12, no. 1, supplement, pp. 1S–77S, 1991. View at Scopus
  49. P. Holvoet, D. H. Lee, M. Steffes, M. Gross, and D. R. Jacobs Jr., “Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome,” The Journal of the American Medical Association, vol. 299, no. 19, pp. 2287–2293, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. R. Masella, R. Varì, M. D'Archivio et al., “Oxidised LDL modulate adipogenesis in 3T3-L1 preadipocytes by affecting the balance between cell proliferation and differentiation,” FEBS Letters, vol. 580, no. 10, pp. 2421–2429, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Nishimura, I. Manabe, M. Nagasaki et al., “Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, and blood vessels,” Diabetes, vol. 56, no. 6, pp. 1517–1526, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. D. Stengel, M. Antonucci, W. Gaoua et al., “Inhibition of LPL expression in human monocyte-derived macrophages is dependent on LDL oxidation state: a key role for lysophosphatidylcholine,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 18, no. 7, pp. 1172–1180, 1998. View at Scopus
  53. M. Merkel, J. Heeren, W. Dudeck et al., “Inactive lipoprotein lipase (LPL) alone increases selective cholesterol ester uptake in vivo, whereas in the presence of active LPL it also increases triglyceride hydrolysis and whole particle lipoprotein uptake,” The Journal of Biological Chemistry, vol. 277, no. 9, pp. 7405–7411, 2002. View at Publisher · View at Google Scholar · View at Scopus
  54. R. Ouedraogo, X. Wu, S. Q. Xu et al., “Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway,” Diabetes, vol. 55, no. 6, pp. 1840–1846, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. D. J. Kennedy, S. Kuchibhotla, K. M. Westfall, R. L. Silverstein, R. E. Morton, and M. Febbraio, “A CD36-dependent pathway enhances macrophage and adipose tissue inflammation and impairs insulin signalling,” Cardiovascular Research, vol. 89, no. 3, pp. 604–613, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. N. Rasouli, A. Yao-Borengasser, V. Varma et al., “Association of scavenger receptors in adipose tissue with insulin resistance in nondiabetic humans,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 9, pp. 1328–1335, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. B. H. Goodpaster, S. Krishnaswami, T. B. Harris et al., “Obesity, regional body fat distribution, and the metabolic syndrome in older men and women,” Archives of Internal Medicine, vol. 165, no. 7, pp. 777–783, 2005. View at Publisher · View at Google Scholar · View at Scopus
  58. P. Holvoet, S. B. Kritchevsky, R. P. Tracy et al., “The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort,” Diabetes, vol. 53, no. 4, pp. 1068–1073, 2004. View at Publisher · View at Google Scholar · View at Scopus
  59. A. Isogawa, M. Yamakado, M. Yano, and T. Shiba, “Serum superoxide dismutase activity correlates with the components of metabolic syndrome or carotid artery intima-media thickness,” Diabetes Research and Clinical Practice, vol. 86, no. 3, pp. 213–218, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Furukawa, T. Fujita, M. Shimabukuro et al., “Increased oxidative stress in obesity and its impact on metabolic syndrome,” The Journal of Clinical Investigation, vol. 114, no. 12, pp. 1752–1761, 2004. View at Publisher · View at Google Scholar · View at Scopus
  61. J. Butler, N. Rodondi, Y. Zhu et al., “Metabolic syndrome and the risk of cardiovascular disease in older adults,” Journal of the American College of Cardiology, vol. 47, no. 8, pp. 1595–1602, 2006. View at Publisher · View at Google Scholar · View at Scopus
  62. G. W. Lyerly, X. Sui, T. S. Church, C. J. Lavie, G. A. Hand, and S. N. Blair, “Maximal exercise electrocardiographic responses and coronary heart disease mortality among men with metabolic syndrome,” Mayo Clinic Proceedings, vol. 85, no. 3, pp. 239–246, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. J. M. Sanchez-Gomez, L. Martinez-Dolz, I. Sanchez-Lazaro, et al., “Influence of metabolic syndrome on development of cardiac allograft vasculopathy in the transplanted heart,” Transplantation, vol. 93, no. 1, pp. 106–111, 2012.
  64. S. M. Grundy, C. E. Barlow, S. W. Farrell, G. L. Vega, and W. L. Haskell, “Cardiorespiratory fitness and metabolic risk,” American Journal of Cardiology, vol. 109, no. 7, pp. 988–993, 2012.
  65. W. S. Wang, M. L. Wahlqvist, C. C. Hsu, H. Y. Chang, W. C. Chang, and C. C. Chen, “Age- and gender-specific population attributable risks of metabolic disorders on all-cause and cardiovascular mortality in Taiwan,” BMC Public Health, vol. 12, article 111, 2012.
  66. L. Zhang, Z. Guo, M. Wu, X. Hu, Y. Xu, and Z. Zhou, “Interaction of smoking and metabolic syndrome on cardiovascular risk in a Chinese cohort,” International Journal of Cardiology. In press. View at Publisher · View at Google Scholar
  67. M. Juonala, C. G. Magnussen, G. S. Berenson, et al., “Childhood adiposity, adult adiposity, and cardiovascular risk factors,” The New England Journal of Medicine, vol. 365, no. 20, pp. 1876–1885, 2011.
  68. J. L. Johnson, C. A. Slentz, J. A. Houmard et al., “Exercise training amount and intensity effects on metabolic syndrome (from Studies of a Targeted Risk Reduction Intervention through Defined Exercise),” American Journal of Cardiology, vol. 100, no. 12, pp. 1759–1766, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. P. Barbeau, M. H. Johnson, C. A. Howe et al., “Ten months of exercise improves general and visceral adiposity, bone, and fitness in black girls,” Obesity, vol. 15, no. 8, pp. 2077–2085, 2007. View at Publisher · View at Google Scholar · View at Scopus
  70. M. A. Ferguson, B. Gutin, N. A. Le et al., “Effects of exercise training and its cessation on components of the insulin resistance syndrome in obese children,” International Journal of Obesity, vol. 23, no. 8, pp. 889–895, 1999. View at Scopus
  71. W. C. Knowler, E. Barrett-Connor, S. E. Fowler et al., “Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin,” The New England Journal of Medicine, vol. 346, no. 6, pp. 393–403, 2002. View at Publisher · View at Google Scholar · View at Scopus
  72. C. L. Davis, N. K. Pollock, J. L. Waller, et al., “Exercise dose and diabetes risk in overweight and obese children: a randomized controlled trial,” The Journal of the American Medical Association, vol. 308, no. 11, pp. 1103–1112, 2012.
  73. C. A. Nixon, H. J. Moore, W. Douthwaite, et al., “Identifying effective behavioural models and behaviour change strategies underpinning preschool- and school-based obesity prevention interventions aimed at 4-6-year-olds: a systematic review,” Obesity Reviews, vol. 13, supplement 1, pp. 106–117, 2012.
  74. R. J. Sigal, G. P. Kenny, N. G. Boulé et al., “Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes: a randomized trial,” Annals of Internal Medicine, vol. 147, no. 6, pp. 357–369, 2007. View at Scopus
  75. C. Y. Christ-Roberts, T. Pratipanawatr, W. Pratipanawatr et al., “Exercise training increases glycogen synthase activity and GLUT4 expression but not insulin signaling in overweight nondiabetic and type 2 diabetic subjects,” Metabolism, vol. 53, no. 9, pp. 1233–1242, 2004. View at Publisher · View at Google Scholar · View at Scopus
  76. R. J. Sigal, G. P. Kenny, D. H. Wasserman, and C. Castaneda-Sceppa, “Physical activity/exercise and type 2 diabetes,” Diabetes Care, vol. 27, no. 10, pp. 2518–2539, 2004. View at Publisher · View at Google Scholar · View at Scopus
  77. E. Goldhammer, D. Ben-Sira, G. Zaid et al., “Paraoxonase activity following exercise-based cardiac rehabilitation program,” Journal of Cardiopulmonary Rehabilitation and Prevention, vol. 27, no. 3, pp. 151–154, 2007. View at Publisher · View at Google Scholar · View at Scopus
  78. T. Fukai, M. R. Siegfried, M. Ushio-Fukai, Y. Cheng, G. Kojda, and D. G. Harrison, “Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training,” The Journal of Clinical Investigation, vol. 105, no. 11, pp. 631–1639, 2000. View at Scopus
  79. N. M. Johannsen, D. L. Swift, W. D. Johnson, et al., “Effect of different doses of aerobic exercise on total white blood cell (WBC) and WBC subfraction number in postmenopausal women: results from DREW,” PLoS One, vol. 7, no. 2, Article ID e31319, 2012.
  80. D. L. Swift, N. M. Johannsen, C. P. Earnest, S. N. Blair, and T. S. Church, “Effect of exercise training modality on C-reactive protein in type 2 diabetes,” Medicine and Science in Sports and Exercise, vol. 44, no. 6, pp. 1028–1034, 2012.
  81. I. G. Fatouros, A. Chatzinikolaou, S. Tournis et al., “Intensity of resistance exercise determines adipokine and resting energy expenditure responses in overweight elderly individuals,” Diabetes Care, vol. 32, no. 12, pp. 2161–2167, 2009. View at Publisher · View at Google Scholar · View at Scopus
  82. C. D. Lee, S. N. Blair, and A. S. Jackson, “Cardiorespiratory fitness, body composition, and all-cause and cardiovascular disease mortality in men,” American Journal of Clinical Nutrition, vol. 69, no. 3, pp. 373–380, 1999. View at Scopus
  83. Q. Qi, Y. Li, A. K. Chomistek, et al., “Television watching, leisure time physical activity, and the genetic predisposition in relation to body mass index in women and men,” Circulation, vol. 126, no. 15, pp. 1821–1827, 2012.
  84. M. J. Abunassar, G. A. Wells, and R. R. Dent, “Smoking status and sex as indicators of differences in 2582 obese patients presenting for weight management,” Vascular Health and Risk Management, vol. 8, pp. 291–298, 2012.
  85. U. Garbin, P. A. Fratta, C. Stranieri, et al., “Cigarette smoking blocks the protective expression of Nrf2/ARE pathway in peripheral mononuclear cells of young heavy smokers favouring inflammation,” PLoS One, vol. 4, no. 12, Article ID e8225, 2009.
  86. H. Tilg, “Obesity, metabolic syndrome and microbiota: multiple interactions,” Journal of Clinical Gastroenterology, vol. 44, supplement 1, pp. S16–S18, 2010. View at Publisher · View at Google Scholar · View at Scopus
  87. H. Shi, M. V. Kokoeva, K. Inouye, I. Tzameli, H. Yin, and J. S. Flier, “TLR4 links innate immunity and fatty acid-induced insulin resistance,” The Journal of Clinical Investigation, vol. 116, no. 11, pp. 3015–3025, 2006. View at Publisher · View at Google Scholar · View at Scopus
  88. P. D. Cani, J. Amar, M. A. Iglesias et al., “Metabolic endotoxemia initiates obesity and insulin resistance,” Diabetes, vol. 56, no. 7, pp. 1761–1772, 2007. View at Publisher · View at Google Scholar · View at Scopus
  89. A. H. M. Terpstra, “Effect of conjugated linoleic acid on body composition and plasma lipids in humans: an overview of the literature,” American Journal of Clinical Nutrition, vol. 79, no. 3, pp. 352–361, 2004. View at Scopus
  90. R. Wall, R. P. Ross, F. Shanahan et al., “Metabolic activity of the enteric microbiota influences the fatty acid composition of murine and porcine liver and adipose tissues,” American Journal of Clinical Nutrition, vol. 89, no. 5, pp. 1393–1401, 2009. View at Publisher · View at Google Scholar · View at Scopus
  91. L. B. Bindels, R. Beck, O. Schakman, et al., “Restoring specific lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model,” PLoS One, vol. 7, no. 6, Article ID e37971, 2012.
  92. A. J. Pyykkönen, K. Räikkönen, T. Tuomi, J. G. Eriksson, L. Groop, and B. Isomaa, “Stressful life events and the metabolic syndrome: the prevalence, prediction and prevention of diabetes (PPP)-botnia study,” Diabetes Care, vol. 33, no. 2, pp. 378–384, 2010. View at Publisher · View at Google Scholar · View at Scopus
  93. R. Pasquali, “The hypothalamic-pituitary-adrenal axis and sex hormones in chronic stress and obesity: pathophysiological and clinical aspects,” Annals of the New York Academy of Sciences, vol. 1264, no. 1, pp. 20–35, 2012.
  94. S. J. Spencer and A. Tilbrook, “The glucocorticoid contribution to obesity,” Stress, vol. 14, no. 3, pp. 233–246, 2011. View at Publisher · View at Google Scholar · View at Scopus
  95. A. K. Garber and R. H. Lustig, “Is fast food addictive?” Current Drug Abuse Reviews, vol. 4, no. 3, pp. 146–162, 2011.
  96. W. Huang, K. M. Ramsey, B. Marcheva, and J. Bass, “Circadian rhythms, sleep, and metabolism,” The Journal of Clinical Investigation, vol. 121, no. 6, pp. 2133–2141, 2011. View at Publisher · View at Google Scholar · View at Scopus
  97. A. R. Gallant, J. Lundgren, and V. Drapeau, “The night-eating syndrome and obesity,” Obesity Reviews, vol. 13, no. 6, pp. 528–536, 2012.
  98. Y. Esquirol, B. Perret, J. B. Ruidavets, et al., “Shift work and cardiovascular risk factors: new knowledge from the past decade,” Archives of Cardiovascular Diseases, vol. 104, no. 12, pp. 636–668, 2011.
  99. J. J. Puder and S. Munsch, “Psychological correlates of childhood obesity,” International Journal of Obesity, vol. 34, supplement 2, pp. S37–S43, 2010. View at Publisher · View at Google Scholar · View at Scopus
  100. C. Gundersen, D. Mahatmya, S. Garasky, and B. Lohman, “Linking psychosocial stressors and childhood obesity,” Obesity Reviews, vol. 12, no. 5, pp. e54–e63, 2011.
  101. D. S. Ludwig, “Weight loss strategies for adolescents: a 14-year-old struggling to lose weight,” The Journal of the American Medical Association, vol. 307, no. 5, pp. 498–508, 2012.
  102. K. W. Dammann and C. Smith, “Food-related environmental, behavioral, and personal factors associated with body mass index among urban, low-income African-American, American Indian, and Caucasian women,” American Journal of Health Promotion, vol. 25, no. 6, pp. e1–e10, 2011.
  103. K. W. Dammann, C. Smith, and R. Richards, “Low-income minority and homeless mothers' perceptions of their 9-13 year-old children's weight status, diet, and health,” Maternal and Child Health Journal, vol. 15, no. 1, pp. 106–114, 2011. View at Publisher · View at Google Scholar · View at Scopus
  104. S. T. Nyberg, K. Heikkila, E. I. Fransson, et al., “Job strain in relation to body mass index: pooled analysis of 160 000 adults from 13 cohort studies,” Journal of Internal Medicine, vol. 272, no. 1, pp. 65–73, 2012.
  105. L. Dubois and M. Girard, “Early determinants of overweight at 4.5 years in a population-based longitudinal study,” International Journal of Obesity, vol. 30, no. 4, pp. 610–617, 2006. View at Publisher · View at Google Scholar · View at Scopus
  106. K. Oliva, G. Barker, C. Riley, et al., “The effect of pre-existing maternal obesity on the placental proteome: two-dimensional difference gel electrophoresis coupled with mass spectrometry,” Journal of Molecular Endocrinology, vol. 48, no. 2, pp. 139–149, 2012.
  107. H. Budge, M. G. Gnanalingham, D. S. Gardner, A. Mostyn, T. Stephenson, and M. E. Symonds, “Maternal nutritional programming of fetal adipose tissue development: long-term consequences for later obesity,” Birth Defects Research C, vol. 75, no. 3, pp. 193–199, 2005. View at Publisher · View at Google Scholar · View at Scopus
  108. R. Han, J. B. Kitlinska, W. R. Munday, G. I. Gallicano, and Z. Zukowska, “Stress hormone epinephrine enhances adipogenesis in murine embryonic stem cells by up-regulating the neuropeptide Y system,” PLoS One, vol. 7, no. 5, Article ID e36609, 2012.
  109. R. Han, A. Li, L. Li, J. B. Kitlinska, and Z. Zukowska, “Maternal low-protein diet up-regulates the neuropeptide Y system in visceral fat and leads to abdominal obesity and glucose intolerance in a sex- and time-specific manner,” The FASEB Journal, vol. 26, no. 8, pp. 3528–3536, 2012.
  110. S. A. Bayol, B. H. Simbi, R. C. Fowkes, and N. C. Stickland, “A maternal “junk food” diet in pregnancy and lactation promotes nonalcoholic fatty liver disease in rat offspring,” Endocrinology, vol. 151, no. 4, pp. 1451–1461, 2010. View at Publisher · View at Google Scholar · View at Scopus
  111. Q. Sun, P. Yue, J. A. Deiuliis et al., “Ambient air pollution exaggerates adipose inflammation and insulin resistance in a mouse model of diet-induced obesity,” Circulation, vol. 119, no. 4, pp. 538–546, 2009. View at Publisher · View at Google Scholar · View at Scopus
  112. X. Xu, Z. Yavar, M. Verdin et al., “Effect of early particulate air pollution exposure on obesity in mice: role of p47phox,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 12, pp. 2518–2527, 2010. View at Publisher · View at Google Scholar · View at Scopus
  113. L. Jacobs, J. Emmerechts, M. F. Hoylaerts et al., “Traffic air pollution and oxidized LDL,” PLoS One, vol. 6, no. 1, Article ID e16200, 2011. View at Publisher · View at Google Scholar · View at Scopus
  114. F. Grün and B. Blumberg, “Endocrine disrupters as obesogens,” Molecular and Cellular Endocrinology, vol. 304, no. 1-2, pp. 19–29, 2009. View at Publisher · View at Google Scholar · View at Scopus
  115. M. Carfi', C. Croera, D. Ferrario et al., “TBTC induces adipocyte differentiation in human bone marrow long term culture,” Toxicology, vol. 249, no. 1, pp. 11–18, 2008. View at Publisher · View at Google Scholar · View at Scopus
  116. F. Grün, H. Watanabe, Z. Zamanian et al., “Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates,” Molecular Endocrinology, vol. 20, no. 9, pp. 2141–2155, 2006. View at Publisher · View at Google Scholar · View at Scopus
  117. T. Kanayama, N. Kobayashi, S. Mamiya, T. Nakanishi, and J. I. Nishikawa, “Organotin compounds promote adipocyte differentiation as agonists of the peroxisome proliferator-activated receptor γ/retinoid X receptor pathway,” Molecular Pharmacology, vol. 67, no. 3, pp. 766–774, 2005. View at Publisher · View at Google Scholar · View at Scopus
  118. L. Nagy, A. Szanto, I. Szatmari, and L. Szeles, “Nuclear hormone receptors enable macrophages and dendritic cells to sense their lipid environment and shape their immune response,” Physiological Reviews, vol. 92, no. 2, pp. 739–789, 2012.
  119. P. Vineis, A. E. Khan, J. Vlaanderen, and R. Vermeulen, “The impact of new research technologies on our understanding of environmental causes of disease: the concept of clinical vulnerability,” Environmental Health, vol. 8, no. 1, article 54, 2009. View at Publisher · View at Google Scholar · View at Scopus
  120. C. V. Breton, H. M. Byun, M. Wenten, F. Pan, A. Yang, and F. D. Gilliland, “Prenatal tobacco smoke exposure affects global and gene-specific DNA methylation,” American Journal of Respiratory and Critical Care Medicine, vol. 180, no. 5, pp. 462–467, 2009. View at Publisher · View at Google Scholar · View at Scopus
  121. A. Baccarelli, R. O. Wright, V. Bollati et al., “Rapid DNA methylation changes after exposure to traffic particles,” American Journal of Respiratory and Critical Care Medicine, vol. 179, no. 7, pp. 572–578, 2009. View at Publisher · View at Google Scholar · View at Scopus
  122. H. Slomko, H. J. Heo, and F. H. Einstein, “Minireview: epigenetics of obesity and diabetes in humans,” Endocrinology, vol. 153, no. 3, pp. 1025–1030, 2012.
  123. R. Stöger, “The thrifty epigenotype: an acquired and heritable predisposition for obesity and diabetes?” BioEssays, vol. 30, no. 2, pp. 156–166, 2008. View at Publisher · View at Google Scholar · View at Scopus
  124. J. A. Duffield, T. Vuocolo, R. Tellam et al., “Intrauterine growth restriction and the sex specific programming of leptin and peroxisome proliferator-activated receptor γ (PPARγ) mRNA expression in visceral fat in the lamb,” Pediatric Research, vol. 66, no. 1, pp. 59–65, 2009. View at Publisher · View at Google Scholar · View at Scopus
  125. I. C. McMillen, L. Rattanatray, J. A. Duffield et al., “The early origins of later obesity: pathways and mechanisms,” Advances in Experimental Medicine and Biology, vol. 646, pp. 71–81, 2009. View at Publisher · View at Google Scholar · View at Scopus
  126. E. Oken and M. W. Gillman, “Fetal origins of obesity,” Obesity Research, vol. 11, no. 4, pp. 496–506, 2003. View at Scopus
  127. K. S. Park, S. K. Kim, M. S. Kim et al., “Fetal and early postnatal protein malnutrition cause long-term changes in rat liver and muscle mitochondria,” Journal of Nutrition, vol. 133, no. 10, pp. 3085–3090, 2003. View at Scopus
  128. V. Lobanenkov, D. Loukinov, and E. Pugacheva, “Environmental epigenomics and disease susceptibility,” Epigenomics, vol. 3, no. 3, pp. 261–266, 2011. View at Publisher · View at Google Scholar · View at Scopus
  129. M. J. R. Heerwagen, M. R. Miller, L. A. Barbour, and J. E. Friedman, “Maternal obesity and fetal metabolic programming: a fertile epigenetic soil,” American Journal of Physiology, vol. 299, no. 3, pp. R711–R722, 2010. View at Publisher · View at Google Scholar · View at Scopus
  130. R. Medzhitov, “Origin and physiological roles of inflammation,” Nature, vol. 454, no. 7203, pp. 428–435, 2008. View at Publisher · View at Google Scholar · View at Scopus
  131. Y. Okada, K. Tateishi, and Y. Zhang, “Histone demethylase JHDM2A is involved in male infertility and obesity,” Journal of Andrology, vol. 31, no. 1, pp. 75–78, 2010. View at Publisher · View at Google Scholar · View at Scopus
  132. K. Tateishi, Y. Okada, E. M. Kallin, and Y. Zhang, “Role of Jhdm2a in regulating metabolic gene expression and obesity resistance,” Nature, vol. 458, no. 7239, pp. 757–761, 2009. View at Publisher · View at Google Scholar · View at Scopus
  133. B. Schwer and E. Verdin, “Conserved metabolic regulatory functions of sirtuins,” Cell Metabolism, vol. 7, no. 2, pp. 104–112, 2008. View at Publisher · View at Google Scholar · View at Scopus
  134. S. Katada, A. Imhof, and P. Sassone-Corsi, “Connecting threads: epigenetics and metabolism,” Cell, vol. 148, no. 1-2, pp. 24–28, 2012.
  135. P. Sassone-Corsi, “Minireview: NAD+, a circadian metabolite with an epigenetic twist,” Endocrinology, vol. 153, no. 1, pp. 1–5, 2012.
  136. J. A. Alegría-Torres, A. Baccarelli, and V. Bollati, “Epigenetics and lifestyle,” Epigenomics, vol. 3, no. 3, pp. 267–277, 2011. View at Publisher · View at Google Scholar · View at Scopus
  137. S. Djuranovic, A. Nahvi, and R. Green, “A parsimonious model for gene regulation by miRNAs,” Science, vol. 331, no. 6017, pp. 550–553, 2011. View at Publisher · View at Google Scholar · View at Scopus
  138. D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  139. P. H. Olsen and V. Ambros, “The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation,” Developmental Biology, vol. 216, no. 2, pp. 671–680, 1999. View at Publisher · View at Google Scholar · View at Scopus
  140. J. Brennecke, D. R. Hipfner, A. Stark, R. B. Russell, and S. M. Cohen, “Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila,” Cell, vol. 113, no. 1, pp. 25–36, 2003. View at Publisher · View at Google Scholar · View at Scopus
  141. M. E. Bordeleau, J. Matthews, J. M. Wojnar et al., “Stimulation of mammalian translation initiation factor eIF4A activity by a small molecule inhibitor of eukaryotic translation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 30, pp. 10460–10465, 2005. View at Publisher · View at Google Scholar · View at Scopus
  142. M. Hulsmans, E. Van Dooren, C. Mathieu, and P. Holvoet, “Decrease of miR-146b-5p in monocytes during obesity is associated with loss of the anti-inflammatory but not insulin signaling action of adiponectin,” PLoS One, vol. 7, no. 2, Article ID e32794, 2012.
  143. M. Hulsmans, P. Sinnaeve, B. Van der Schueren, C. Mathieu, S. Janssens, and P. Holvoet, “Decreased miR-181a expression in monocytes of obese patients is associated with the occurrence of metabolic syndrome and coronary artery disease,” The Journal of Clinical Endocrinology & Metabolism, vol. 97, no. 7, pp. E1213–E1218, 2012.
  144. L. Jaskiewicz and W. Filipowicz, “Role of Dicer in posttranscriptional RNA silencing,” Current Topics in Microbiology and Immunology, vol. 320, pp. 77–97, 2008. View at Publisher · View at Google Scholar · View at Scopus
  145. S. Haramati, I. Navon, O. Issler, et al., “MicroRNA as repressors of stress-induced anxiety: the case of amygdalar miR-34,” The Journal of Neuroscience, vol. 31, no. 40, pp. 14191–14203, 2011.
  146. H. M. Heneghan, N. Miller, and M. J. Kerin, “Role of microRNAs in obesity and the metabolic syndrome,” Obesity Reviews, vol. 11, no. 5, pp. 354–361, 2010. View at Publisher · View at Google Scholar · View at Scopus
  147. B. Mayr and M. Montminy, “Transcriptional regulation by the phosphorylation-dependent factor creb,” Nature Reviews Molecular Cell Biology, vol. 2, no. 8, pp. 599–609, 2001. View at Publisher · View at Google Scholar · View at Scopus
  148. I. Shaked, A. Meerson, Y. Wolf et al., “MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase,” Immunity, vol. 31, no. 6, pp. 965–973, 2009. View at Publisher · View at Google Scholar · View at Scopus
  149. V. Plaisance, A. Abderrahmani, V. Perret-Menoud, P. Jacquemin, F. Lemaigre, and R. Regazzi, “MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells,” The Journal of Biological Chemistry, vol. 281, no. 37, pp. 26932–26942, 2006. View at Publisher · View at Google Scholar · View at Scopus
  150. F. Bazzoni, M. Rossato, M. Fabbri et al., “Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 13, pp. 5282–5287, 2009. View at Publisher · View at Google Scholar · View at Scopus
  151. A. M. Krichevsky, K. C. Sonntag, O. Isacson, and K. S. Kosik, “Specific MicroRNAs modulate embryonic stem cell-derived neurogenesis,” Stem Cells, vol. 24, no. 4, pp. 857–864, 2006. View at Publisher · View at Google Scholar · View at Scopus
  152. H. Wang, B. R. Gauthier, K. A. Hagenfeldt-Johansson, M. Iezzi, and C. B. Wollheim, “Foxa2 (HNF3β) controls multiple genes implicated in metabolism-secretion coupling of glucose-induced insulin release,” The Journal of Biological Chemistry, vol. 277, no. 20, pp. 17564–17570, 2002. View at Publisher · View at Google Scholar · View at Scopus
  153. Y. Nakahata, B. Grimaldi, S. Sahar, J. Hirayama, and P. Sassone-Corsi, “Signaling to the circadian clock: plasticity by chromatin remodeling,” Current Opinion in Cell Biology, vol. 19, no. 2, pp. 230–237, 2007. View at Publisher · View at Google Scholar · View at Scopus
  154. M. Pegoraro and E. Tauber, “The role of microRNAs (miRNA) in circadian rhythmicity,” Journal of Genetics, vol. 87, no. 5, pp. 505–511, 2008. View at Scopus
  155. M. C. Mitterberger, S. Lechner, M. Mattesich, et al., “DLK1(PREF1) is a negative regulator of adipogenesis in CD105(+)/CD90(+)/CD34(+)/CD31(-)/FABP4(-) adipose-derived stromal cells from subcutaneous abdominal fat pats of adult women,” Stem Cell Research, vol. 9, no. 1, pp. 35–48, 2012.
  156. S. K. Laine, J. J. Alm, S. P. Virtanen, H. T. Aro, and T. K. Laitala-Leinonen, “MicroRNAs miR-96, miR-124, and miR-199a regulate gene expression in human bone marrow-derived mesenchymal stem cells,” Journal of Cellular Biochemistry, vol. 113, no. 8, pp. 2687–2695, 2012.
  157. Q. Q. Tang and M. D. Lane, “Adipogenesis: from stem cell to adipocyte,” Annual Review of Biochemistry, vol. 81, pp. 715–736, 2012.
  158. E. John, A. Wienecke-Baldacchino, M. Liivrand, M. Heinaniemi, C. Carlberg, and L. Sinkkonen, “Dataset integration identifies transcriptional regulation of microRNA genes by PPARgamma in differentiating mouse 3T3-L1 adipocytes,” Nucleic Acids Research, vol. 40, no. 10, pp. 4446–4460, 2012.
  159. H. M. Heneghan, N. Miller, O. J. McAnena, T. O'Brien, and M. J. Kerin, “Differential miRNA expression in omental adipose tissue and in the circulation of obese patients identifies novel metabolic biomarkers,” The Journal of Clinical Endocrinology & Metabolism, vol. 96, no. 5, pp. E846–E850, 2011. View at Publisher · View at Google Scholar · View at Scopus
  160. N. Singh, E. A. Shirdel, L. Waldron, R. H. Zhang, I. Jurisica, and E. M. Comelli, “The murine caecal microRNA signature depends on the presence of the endogenous microbiota,” International Journal of Biological Sciences, vol. 8, no. 2, pp. 171–186, 2012.
  161. P. M. Borralho, A. E. Simoes, S. E. Gomes, et al., “MiR-143 overexpression impairs growth of human colon carcinoma xenografts in mice with induction of apoptosis and inhibition of proliferation,” PLoS One, vol. 6, no. 8, Article ID e23787, 2011.
  162. H. Xie, B. Lim, and H. F. Lodish, “MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity,” Diabetes, vol. 58, no. 5, pp. 1050–1057, 2009. View at Publisher · View at Google Scholar · View at Scopus
  163. S. D. Jordan, M. Krüger, D. M. Willmes et al., “Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism,” Nature Cell Biology, vol. 13, no. 4, pp. 434–446, 2011. View at Publisher · View at Google Scholar · View at Scopus
  164. R. Nagel, L. Clijsters, and R. Agami, “The miRNA-192/194 cluster regulates the period gene family and the circadian clock,” FEBS Journal, vol. 276, no. 19, pp. 5447–5455, 2009. View at Publisher · View at Google Scholar · View at Scopus
  165. M. A. Reddy, W. Jin, L. Villeneuve, et al., “Pro-inflammatory role of microrna-200 in vascular smooth muscle cells from diabetic mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 3, pp. 721–729, 2012.
  166. H. Fayyad-Kazan, R. Rouas, M. Fayyad-Kazan, et al., “MicroRNA profile of circulating CD4-positive regulatory T cells in human adults and impact of differentially expressed microRNAs on expression of two genes essential to their function,” The Journal of Biological Chemistry, vol. 287, no. 13, pp. 9910–9922, 2012.
  167. V. Bollati and A. Baccarelli, “Environmental epigenetics,” Heredity, vol. 105, no. 1, pp. 105–112, 2010. View at Publisher · View at Google Scholar · View at Scopus
  168. P. Parra, F. Serra, and A. Palou, “Expression of adipose MicroRNAs Is sensitive to dietary conjugated linoleic acid treatment in mice,” PLoS One, vol. 5, no. 9, Article ID e13005, 2010. View at Publisher · View at Google Scholar · View at Scopus
  169. J. W. Holloway, F. S. Savarimuthu, K. M. Fong, and I. A. Yang, “Genomics and the respiratory effects of air pollution exposure,” Respirology, vol. 17, no. 4, pp. 590–600, 2012.
  170. M. J. Jardim, R. C. Fry, I. Jaspers, L. Dailey, and D. Diaz-Sanchez, “Disruption of MicroRNA expression in human airway cells by diesel exhaust particles is linked to tumorigenesis-associated pathways,” Environmental Health Perspectives, vol. 117, no. 11, pp. 1745–1751, 2009. View at Publisher · View at Google Scholar · View at Scopus
  171. A. Fleischman, S. E. Shoelson, R. Bernier, and A. B. Goldfine, “Salsalate improves glycemia and inflammatory parameters in obese young adults,” Diabetes Care, vol. 31, no. 2, pp. 289–294, 2008. View at Publisher · View at Google Scholar · View at Scopus
  172. G. L. Pierce, L. A. Lesniewski, B. R. Lawson, S. D. Beske, and D. R. Seals, “Nuclear factor-κB activation contributes to vascular endothelial dysfunction via oxidative stress in overweight/obese middle-aged and older humans,” Circulation, vol. 119, no. 9, pp. 1284–1292, 2009. View at Publisher · View at Google Scholar · View at Scopus
  173. M. J. van Erk, S. Wopereis, C. Rubingh et al., “Insight in modulation of inflammation in response to diclofenac intervention: a human intervention study,” BMC Medical Genomics, vol. 3, article 5, 2010. View at Publisher · View at Google Scholar · View at Scopus
  174. T. L. Stanley, M. V. Zanni, S. Johnsen et al., “TNF-α antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome,” The Journal of Clinical Endocrinology & Metabolism, vol. 96, no. 1, pp. E146–E150, 2011. View at Publisher · View at Google Scholar · View at Scopus
  175. A. Camins, F. X. Sureda, F. Junyent et al., “Sirtuin activators: designing molecules to extend life span,” Biochimica et Biophysica Acta, vol. 1799, no. 10–12, pp. 740–749, 2010. View at Publisher · View at Google Scholar · View at Scopus
  176. S. Li, H. J. Shin, E. L. Ding, and R. M. van Dam, “Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis,” The Journal of the American Medical Association, vol. 302, no. 2, pp. 179–188, 2009. View at Publisher · View at Google Scholar · View at Scopus
  177. S. A. Phillips and J. T. Kung, “Mechanisms of adiponectin regulation and use as a pharmacological target,” Current Opinion in Pharmacology, vol. 10, no. 6, pp. 676–683, 2010. View at Publisher · View at Google Scholar · View at Scopus
  178. B. Gallwitz, J. Guzman, F. Dotta, et al., “Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised controlled trial,” The Lancet, vol. 379, no. 9833, pp. 2270–2278, 2012.
  179. A. Chaudhuri, H. Ghanim, M. Vora, et al., “Exenatide exerts a potent antiinflammatory effect,” The Journal of Clinical Endocrinology & Metabolism, vol. 97, no. 1, pp. 198–207, 2012.
  180. G. J. Soleas, E. P. Diamandis, and D. M. Goldberg, “Resveratrol: a molecule whose time has come? And gone?” Clinical Biochemistry, vol. 30, no. 2, pp. 91–113, 1997. View at Publisher · View at Google Scholar · View at Scopus
  181. S. Stojanović, H. Sprinz, and O. Brede, “Efficiency and mechanism of the antioxidant action of trans-resveratrol and its analogues in the radical liposome oxidation,” Archives of Biochemistry and Biophysics, vol. 391, no. 1, pp. 79–89, 2001. View at Publisher · View at Google Scholar · View at Scopus
  182. P. Brito, L. M. Almeida, and T. C. P. Dinis, “The interaction of resveratrol with ferrylmyoglobin and peroxynitrite; protection against LDL oxidation,” Free Radical Research, vol. 36, no. 6, pp. 621–631, 2002. View at Publisher · View at Google Scholar · View at Scopus
  183. E. N. Frankel, A. L. Waterhouse, and J. E. Kinsella, “Inhibition of human LDL oxidation by resveratrol,” The Lancet, vol. 341, no. 8852, pp. 1103–1104, 1993. View at Scopus
  184. L. E. Donnelly, R. Newton, G. E. Kennedy et al., “Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms,” American Journal of Physiology, vol. 287, no. 4, pp. L774–L783, 2004. View at Publisher · View at Google Scholar · View at Scopus
  185. M. C. Pinto, J. A. García-Barrado, and P. Macías, “Resveratrol is a potent inhibitor of the dioxygenase activity of lipoxygenase,” Journal of Agricultural and Food Chemistry, vol. 47, no. 12, pp. 4842–4846, 1999. View at Publisher · View at Google Scholar · View at Scopus
  186. C. A. de la Lastra and I. Villegas, “Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications,” Molecular Nutrition and Food Research, vol. 49, no. 5, pp. 405–430, 2005. View at Publisher · View at Google Scholar · View at Scopus
  187. S. Shankar, I. Siddiqui, and R. K. Srivastava, “Molecular mechanisms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells,” Molecular and Cellular Biochemistry, vol. 304, no. 1-2, pp. 273–285, 2007. View at Publisher · View at Google Scholar · View at Scopus
  188. Z. Wang, Y. Huang, J. Zou, K. Cao, Y. Xu, and J. M. Wu, “Effects of red wine and wine polyphenol resveratrol on platelet aggregation in vivo and in vitro,” International Journal of Molecular Medicine, vol. 9, no. 1, pp. 77–79, 2002. View at Scopus
  189. C. K. Chen and C. R. Pace-Asciak, “Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta,” General Pharmacology, vol. 27, no. 2, pp. 363–366, 1996. View at Publisher · View at Google Scholar · View at Scopus
  190. L. M. Szewczuk, L. Forti, L. A. Stivala, and T. M. Penning, “Resveratrol is a peroxidase-mediated inactivator of COX-1 but not COX-2: a mechanistic approach to the design of COX-1 selective agents,” The Journal of Biological Chemistry, vol. 279, no. 21, pp. 22727–22737, 2004. View at Publisher · View at Google Scholar · View at Scopus
  191. S. H. Tsai, S. Y. Lin-Shiau, and J. K. Lin, “Suppression of nitric oxide synthase and the down-regulation of the activation of NFκB in macrophages by resveratrol,” British Journal of Pharmacology, vol. 126, no. 3, pp. 673–680, 1999. View at Publisher · View at Google Scholar · View at Scopus
  192. S. Bradamante, L. Barenghi, and A. Villa, “Cardiovascular protective effects of resveratrol,” Cardiovascular Drug Reviews, vol. 22, no. 3, pp. 169–188, 2004. View at Scopus
  193. O. Vang, N. Ahmad, C. A. Baile et al., “What is new for an old molecule? systematic review and recommendations on the use of resveratrol,” PLoS One, vol. 6, no. 6, Article ID e19881, 2011. View at Publisher · View at Google Scholar · View at Scopus
  194. G. C. M. Bakker, M. J. van Erk, L. Pellis et al., “An antiinflammatory dietary mix modulates inflammation and oxidative and metabolic stress in overweight men: a nutrigenomics approach,” American Journal of Clinical Nutrition, vol. 91, no. 4, pp. 1044–1059, 2010. View at Publisher · View at Google Scholar · View at Scopus
  195. J. A. Wise, G. R. Kaats, H. G. Preuss, and R. J. Morin, “β-Carotene and α-tocopherol in healthy overweight adults; depletion kinetics are correlated with adiposity,” International Journal of Food Sciences and Nutrition, vol. 60, supplement 3, pp. 65–75, 2009. View at Publisher · View at Google Scholar · View at Scopus
  196. D. P. Brostow, A. T. Hirsch, T. C. Collins, and M. S. Kurzer, “The role of nutrition and body composition in peripheral arterial disease,” Nature Reviews Cardiology, vol. 9, no. 11, pp. 634–643, 2012. View at Publisher · View at Google Scholar
  197. T. Münzel, T. Gori, R. M. Bruno, and S. Taddei, “Is oxidative stress a therapeutic target in cardiovascular disease?” European Heart Journal, vol. 31, no. 22, pp. 2741–2748, 2010. View at Publisher · View at Google Scholar · View at Scopus
  198. A. Schramm, P. Matusik, G. Osmenda, and T. J. Guzik, “Targeting NADPH oxidases in vascular pharmacology,” Vascular Pharmacology, vol. 56, no. 5-6, pp. 216–231, 2012.
  199. E. van Rooij, W. S. Marshall, and E. N. Olson, “Toward microRNA-based therapeutics for heart disease: the sense in antisense,” Circulation Research, vol. 103, no. 9, pp. 919–928, 2008. View at Publisher · View at Google Scholar · View at Scopus
  200. M. Hatziapostolou, C. Polytarchou, E. Aggelidou, et al., “An HNF4alpha-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis,” Cell, vol. 147, no. 6, pp. 1233–1247, 2011.
  201. E. D. Ponomarev, T. Veremeyko, and H. L. Weiner, “MicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNS,” Glia, vol. 61, no. 1, pp. 91–103, 2013.